Healthcare companies are lining up to go public, and they could get a warmer reception in 2010 as investors' risk appetite increases, and new legislation potentially leads to more profit for the sector. The US S… Read more
Join this Free Investor Network For:
- consensus poll results of BioPharma buy & sell ideas
- network with like minded investors
- contribute your data & comments to the community
- 100% Free
- to register & access community stock rating votes
Latest News
Outlook for healthcare IPOs improving for 2010
|
ReNeuron trials - Injecting Cells Into Brains Means Test for Investors
In Scotland a patient will be the first of 12 men disabled by strokes plans to have hole drilled in the patient’s skull, a needle inserted and injection of 2 million stem cells from ReNeuron into his … Read more |
Latest Blogs
 |
How is Beckman these days in the tools for researc…
How is beckman these days in the tools for research space? In particluar assay kits and robtoics? Is… Read more
|
 |
Multiple products but low price?
Ignoring the Phase II failure today, can someone elaborate as to why the market cap of this compnay … Read more
|
 |
Will Abbott be a re-bound stock given low level an…
Will Abbott be a re-bound stock given the low price level it has reached over the recent year or so … Read more
|
 |
Is it a good time to get into Sequenome looking fo…
Is it a good time to get into Sequenome looking for a rebound after the CEO removal? The other consi… Read more
|
Latest Videos
- Spotlight on Osiris Therapeutics - Interview with CEO Randal Mills
- BioTime a biotechnology company focused on stem cell technology and regenerative medicine
- Update on Diabetes in the USA
- There are fears that H1N1 has now mutated and resembles the Spanish flu virus
- Early data back Thoratec's HeartMate II as destination therapy
Most Popular Companies
Biotechnology index
Pharmaceutical Index
About this free investor community in brief
This biotechnology investor community provides tools to compare thoughts on publicly listed (NYSE, NASDAQ, DOW) and private companies dealing in such product areas as: drug development, healthcare, drug delivery, medical devices, nanotechnology, pharmaceuticals, diagnostics, bioinformatics, medical software & Venture Capital. In addition to company stock prices and company synopsis the website includes investor member opinions generated through Web 2.0 tools such as BLOGS & POLLS (which are summed to give a community consensus vote on buy, sell, hold actions). Understanding the terms of service before using the website is essential to understand how these social network investing features operate.
Australian sister website for the Biotech & medical ASX space is at: www.bioinvest.com.au